Walvax Biotechnology Co., Ltd. (SHE:300142)
11.85
-0.51 (-4.13%)
Mar 2, 2026, 3:04 PM CST
-3.42% (1Y)
| Market Cap | 19.77B |
| Revenue (ttm) | 2.40B |
| Net Income (ttm) | 49.24M |
| Shares Out | 1.60B |
| EPS (ttm) | 0.03 |
| PE Ratio | 401.42 |
| Forward PE | 76.06 |
| Dividend | 0.03 (0.24%) |
| Ex-Dividend Date | Jan 9, 2026 |
| Volume | 40,294,586 |
| Average Volume | 58,839,757 |
| Open | 12.18 |
| Previous Close | 12.36 |
| Day's Range | 11.81 - 12.24 |
| 52-Week Range | 9.70 - 14.65 |
| Beta | 0.57 |
| RSI | 50.76 |
| Earnings Date | Mar 28, 2026 |